Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Covid-19 Vaccination on Reducing the Risk of Infection, Hospitalization, and Death in Isfahan Province, Iran



Taherian Z1 ; Rezaei M1 ; Haddadpour A1 ; Amini Z2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Vice-Chancellor for Health, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Community and Family Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Iranian Journal of Public Health Published:2022

Abstract

Background: We aimed to evaluate the effect of COVID-19 vaccines in preventing infection, hospitalization, and mortality due to COVID-19 in Isfahan Province, Iran. Methods: Following a retrospective cohort design, data of all vaccinated individuals since the rollout of vaccination of the general population are analyzed, Mar 2020 to Aug 13, 2021. Moreover, the data of all non-vaccinated people were collected by the census method for this period. The two groups were compared concerning hospitalization and mortality using the Chi-square test. Kaplan-Meyer was also used to calculate the median interval between receiving a vaccine and outcome (hospitalization and death). Results: Overall, 583434 people have received a second dose of a vaccine from Mar 2020 to Aug 2021, which 74% (n=433403) was Sinopharm, 18.2% (n=106027) AstraZeneca, 3.6% (n=21216) Sputnik, and 3.9% (n=22,788) Barekat. In contrast, 2,551,140 people living in the Isfahan Province did not receive a vaccine. The median interval between injection of the first dose and the hospitalization for those who received Sinopharm, AstraZeneca, Sputnik, and Barekat was 22, 61, 19, and 19 days, respectively. For unvaccinated cases, the rates of infection, hospitalization, and mortality (per 1000 population) were 69.7, 12.1, and 1.04, respectively. In contrast, for vaccinated individuals, these rates were 3.9, 1.08, and 0.09, two weeks after the second dose, respectively. Conclusion: The highest and lowest reduction in relative risk was for those who received AstraZeneca and Sputnik, respectively. © 2022, Tehran University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Importance of the Covid-19 Vaccine Booster Dose in Protection and Immunity, Vaccines (2022)
2. Immunization Coverage of Children Aged 24–35 Months in the Islamic Republic of Iran: A National Cluster Coverage Survey; [Couverture Vaccinale Des Enfants Ages De 24 a 35 Mois En Republique Islamique D'iran: Enquete Nationale De Couverture Par Sondage En Grappes], Eastern Mediterranean Health Journal (2022)
3. A Prospective Cohort Study Protocol: Monitoring and Surveillance of Adverse Events Following Heterologous Booster Doses of Oxford Astrazeneca Covid-19 Vaccine in Previous Recipients of Two Doses of Sinopharm or Sputnik V Vaccines in Iran, BMC Public Health (2023)
4. Covid-19 Vaccines Cost-Effectiveness Analysis: A Scenario for Iran, Vaccines (2022)
5. Monitoring and Active Surveillance of Adverse Events Following the Booster Dose of Azd1222 Vaccine in People Vaccinated With Sinopharm Bbibp-Corv: A Cohort Study, BMC Public Health (2025)
6. Covid-19 Breakthrough Infections Among Patients With Cancer Receiving Sinopharm Bibp Vaccine, International Journal of Cancer Management (2022)
7. A Population-Based and Symptom-Based Covid-19 Prevalence Survey, Journal of Education and Health Promotion (2023)
8. Comparative Study of the Level of Neutralizing Antibodies in People Injecting 4 Types of Covid-19 Vaccine; [بررسیمقایسهایسطح آنتیبادیخنثیکنندهدر افراد تزریقکنندهی4نوع واکسن کووید-], Journal of Isfahan Medical School (2024)
Experts (# of related papers)
View all Related Experts
Roya Kelishadi (10)
Shaghayegh Haghjooy Javanmard (7)
Other Related Docs
9. A Cross-Sectional Study on the Reasons for Vaccine Hesitancy in Children Under Seven Years of Age in Isfahan, Iran, Vaccine: X (2023)
10. Effectiveness of Bbibp-Corv Vaccine in Preventing Sars-Cov2 Infection and Severe Outcomes in People Living With Multiple Sclerosis: A Population-Based Study, Multiple Sclerosis and Related Disorders (2023)
11. Epidemiological Features of Covid-19 in Iran, Journal of Research in Medical Sciences (2022)
12. Efficacy and Safety of an Inactivated Virus-Particle Vaccine for Sars-Cov-2, Biv1-Coviran: Randomised, Placebo Controlled, Double Blind, Multicentre, Phase 3 Clinical Trial, BMJ (2023)
13. Effect of Multiple Sclerosis Disease-Modifying Therapies on the Real-World Effectiveness of Two Doses of Bbibp-Corv (Sinopharm) Vaccine, Journal of the Neurological Sciences (2023)
14. Covid-19 Infection Risk Following Elective Arthroplasty and Surgical Complications in Covid-19-Vaccinated Patients: A Multicenter Comparative Cohort Study, Arthroplasty Today (2022)
15. Lactate Dehydrogenase to Albumin Ratio As a Predictive Factor of Covid-19 Patients’ Outcome; a Cross-Sectional Study, Archives of Academic Emergency Medicine (2022)
16. Association of Prior Covid‑19 Infection With Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran, International Journal of Preventive Medicine (2024)
17. Timing and Delay in Children Vaccination; Evaluation of Expanded Program of Immunization in Outskirt of Iranian Cities, Journal of Research in Health Sciences (2015)
18. A Comprehensive Review on Various Aspects of Sars-Cov-2 (Covid-19) Vaccines, International Journal of Preventive Medicine (2022)
19. Knowledge and Attitude Toward Human Papillomavirus and Hpv Vaccination in Iranian Population: A Systematic Review, Asian Pacific Journal of Cancer Prevention (2019)
20. Risk Factors for the Mortality in Hospitalized Patients With Covid-19: A Brief Report, Iranian Journal of Medical Sciences (2021)
21. The Use of Medicinal Plants in the Prevention of Covid-19 Using the Health Belief Model: A Survey Based on the Iranian Population, Journal of Education and Health Promotion (2023)
22. Iranian Pediatric Covid-19 Epidemiology and Clinical Characteristics, Canadian Journal of Infectious Diseases and Medical Microbiology (2021)
23. Designing and Psychometric Assessment of the Scale of Factors Influencing Hpv Vaccine Uptake Behaviors in Young Adults, Infectious Agents and Cancer (2022)
24. Seroprevalence of Hepatitis a in Iranian Adolescents: Is It Time to Introduce a Vaccine?, Epidemiology and Infection (2016)
25. Acute Adverse Events Following Immunization With Dtp-Hb-Hib Pentavalent Vaccine in the First Year of Life; [Manifestations Postvaccinales Indesirables Aigues Liees Au Vaccin Pentavalent Dtchb-Hib Au Cours De La Premiere Annee De Vie], Eastern Mediterranean Health Journal (2023)
26. Death Portrait of Isfahan Province in Years 2007-2011, International Journal of Preventive Medicine (2016)
27. Factors Related to Preventive Covid-19 Behaviors Using Health Belief Model Among General Population: A Cross-Sectional Study in Iran, BMC Public Health (2021)
28. Cancer in Iran 2008 to 2025: Recent Incidence Trends and Short-Term Predictions of the Future Burden, International Journal of Cancer (2021)
29. Electrolyte Abnormalities in Hospitalized Covid-19 Patients at Tertiary Referral Centers in Tehran: Hypermagnesemia As a Marker of Fatality: A Retrospective Cross-Sectional Study, Health Science Reports (2023)
30. Risk Factors, Clinical, and Laboratory Characteristics of Patients With a Diagnosis of Covid-19, Journal of Emergency Practice and Trauma (2022)
31. Age-Dependent Clinical Features and Prognosis of Covid-19 Patients, Tanaffos (2021)
32. Risk Factors for In-Hospital Mortality Among Patients With Coronavirus-19 in Isfahan City, Iran, Advanced Biomedical Research (2022)
33. Use of Complementary and Alternative Medicine in General Population During Covid-19 Outbreak: A Survey in Iran, Journal of Integrative Medicine (2022)
34. Transitional Epidemiology of Human Papillomavirus Infection in Iran: A Cross‑Sectional Study and National Review, Advanced Biomedical Research (2023)
35. Effects of the Covid-19 Pandemic on Healthcare Delivery to an Immigrant Population in the Islamic Republic of Iran; [Effets De La Pandemie De Covid-19 Sur La Prestation De Soins De Sante Dans Une Population Immigree En Republique Islamique D'iran], Eastern Mediterranean Health Journal (2022)
36. Outcomes of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase, Stroke (2022)
37. Mortality-Related Factors Disparity Among Iranian Deceased Children Aged 1-59 Months According to the Medical Activities in Emergency Units: National Mortality Surveillance System, Journal of Research in Medical Sciences (2012)
38. Sars-Cov-2 Serology Among People With Multiple Sclerosis on Disease-Modifying Therapies After Bbibp-Corv (Sinopharm) Inactivated Virus Vaccination: Same Story, Different Vaccine, Multiple Sclerosis and Related Disorders (2022)
39. The Information Needs of the Iranian People in the Covid-19 Pandemic From the Perspective of Health Professionals: A Qualitative Approach, Journal of Education and Community Health (2021)
40. Co-Infection Between the Severe Acute Respiratory Syndrome Coronavirus 2 and the Influenza Type B in Isfahan, Iran, Journal of Research in Medical Sciences (2021)
41. Risk Factors Associated With Severity and Death From Covid-19 in Iran: A Systematic Review and Meta-Analysis Study, Journal of Intensive Care Medicine (2023)
42. Covid-19 Vaccine Boosters: The Good, the Bad, and the Ugly, Vaccines (2021)
43. Survival Analysis for Predictive Factors of Delay Vaccination in Iranian Children, International Journal of Preventive Medicine (2015)
44. Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of Covid.19 Pandemic: A Narrative Review, International Journal of Preventive Medicine (2021)
45. Isfahan Covid Cohort Study: Rationale, Methodology, and Initial Results, Journal of Research in Medical Sciences (2022)
46. Opium and Tobacco Use, and Outcome in Covid-19 Infected Patients: A Cross-Sectional Study, International Journal of High Risk Behaviors and Addiction (2024)
47. Evaluation of Influenza Vaccine Effectiveness and Effective Factors of Accepting Vaccine Injection Among Health Care Workers in Alzahra Hospital, Isfahan, Iran, 2018, Journal of Isfahan Medical School (2020)
48. The Effect of Coronavirus Disease Pandemic on Maternal and Neonatal Health: A Cohort Study From Isfahan, Iran, International Journal of Reproductive BioMedicine (2023)
49. Mortality Inequality in 1-59 Months Children Across Iranian Provinces: Referring System and Determinants of Death Based on Hospital Records, International Journal of Preventive Medicine (2013)
50. Efficacy and Side Effects of Sputnik V, Sinopharm and Astrazeneca Vaccines to Stop Covid-19; a Review and Discussion, Immunopathologia Persa (2021)